Ironwood Pharmaceuticals Inc Capital Reinvestment Ratio
Ironwood Pharmaceuticals Inc capital reinvestment ratio. Ironwood Pharmaceuticals Inc (IRWD) has a Capital Reinvestment Ratio of 0.00x as of December 2025, meaning it reinvests 0% of its operating cash flow ($74.58 Million) in capital expenditures ($1.00K). Check Ironwood Pharmaceuticals Inc (IRWD) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Ironwood Pharmaceuticals Inc (2019–2025)
Capital reinvestment ratio of Ironwood Pharmaceuticals Inc from 2019 to 2025. This chart tracks Ironwood Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. Also explore IRWD net asset momentum to track the company's year-over-year net asset growth rate.
Ironwood Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2019–2025)
Ironwood Pharmaceuticals Inc capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see IRWD cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $127.04 Million | $34.00K | ▼ -80.5% |
| 2024 | 0.00x | $103.55 Million | $142.00K | ▼ -7.9% |
| 2023 | 0.00x | $183.43 Million | $273.00K | ▲ +199.6% |
| 2022 | 0.00x | $273.76 Million | $136.00K | ▼ -50.9% |
| 2021 | 0.00x | $261.89 Million | $265.00K | ▼ -90.7% |
| 2020 | 0.01x | $168.84 Million | $1.84 Million | ▼ -98.4% |
| 2019 | 0.67x | $10.72 Million | $7.19 Million | — |